SC2i Tissue and Data Repository Protocol
Status: | Recruiting |
---|---|
Conditions: | Hospital |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 8/5/2018 |
Start Date: | November 2014 |
End Date: | October 2019 |
Surgical Critical Care InitiativeTissue and Data Acquisition Protocol
The purpose of this study is to collect samples of blood, urine, cerebrospinal fluid (CSF,
the fluid that surrounds the brain and spinal cord), wound tissue and/or wound fluids, and
other body fluids and tissues from people who have been seriously injured or ill. The samples
will be used to develop and assess tests and/or tools that doctors can use to decide the best
treatment plan for seriously injured or ill military personnel and for civilians. Additonal
protocols to use the samples will be submitted as separate protocols.
the fluid that surrounds the brain and spinal cord), wound tissue and/or wound fluids, and
other body fluids and tissues from people who have been seriously injured or ill. The samples
will be used to develop and assess tests and/or tools that doctors can use to decide the best
treatment plan for seriously injured or ill military personnel and for civilians. Additonal
protocols to use the samples will be submitted as separate protocols.
Inclusion Criteria:
- Patients with injury or illness requiring surgical care or treatment in a critical
care or emergency setting who are being cared for at SC2I sites (Grady Memorial
Hospital, Emory Univeristy Hospital, and Duke University Health Systems)
- Healthy volunteer control subjects to include individuals without any known injury or
end-stage organ disease and patients who have recovered from prior injury.
- Ability to understand the purposes and risks of the study and willingly give written
informed consent, or in the case of incapacitated patients, a willing surrogate able
to give written informed consent.
Exclusion Criteria:
- Any condition that, in the opinion of the attending physician, would place the patient
or volunteer subject at undue risk by participating. Specific conditions include but
are not limited to anemia prohibitive of phlebotomy, coagulopathy, or technical
considerations that would prevent acquisition of sufficient tissue or fluid for
clinical use. Acquisition of samples from patients requiring active transfusion or
with transfusion-associated coagulopathy will be considered as appropriate study
candidates at the discretion of the attending physician.
We found this trial at
3
sites
Durham, North Carolina 27710
Principal Investigator: Allan Krik, MD, Ph.D
Phone: 919-681-4853
Click here to add this to my saved trials
201 Dowman Dr
Atlanta, Georgia 30303
Atlanta, Georgia 30303
(404) 727-6123
Principal Investigator: Timothy G Buchman, Ph.D., MD
Phone: 404-712-2602
Emory University Emory University, recognized internationally for its outstanding liberal artscolleges, graduate and professional schools,...
Click here to add this to my saved trials
Atlanta, Georgia 30303
Principal Investigator: Christopher J. Dente, MD
Phone: 404-251-8915
Click here to add this to my saved trials